Advanced Flower Capital (AFCG) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
10 Mar, 2026Executive summary
Announced intention to convert from a REIT to a BDC to expand investment opportunities beyond real estate-backed cannabis operators, subject to shareholder approval, with conversion targeted for Q1 2026.
Board approved an expanded investment mandate to include direct lending outside the cannabis industry, aiming for greater diversification and risk-adjusted returns.
Reported GAAP net loss of $13.2 million for Q2 2025, with distributable earnings of $3.4 million.
Management remains focused on managing underperforming loans, maximizing recoveries, and resolving non-accrual credits, with ongoing legal actions and asset liquidations.
First Nasdaq-listed commercial mortgage REIT focused on institutional loans to state-compliant cannabis operators, with $917 million total commitments since inception.
Financial highlights
Q2 2025 distributable earnings were $3.4 million ($0.15 per share); GAAP net loss was $13.2 million ($0.60 per share).
Q2 2025 interest income was $8.1 million, net interest income was $6.2 million.
Book value per share was $8.18 as of June 30, 2025.
Paid a $0.15 per share dividend for Q2 2025.
Total assets as of June 30, 2025 were $298.6 million; shareholder equity was $184.7 million.
Outlook and guidance
Conversion to BDC expected to broaden the investment universe, allowing lending to non-real estate and ancillary cannabis businesses, and to other middle-market companies.
Management anticipates the need to raise additional equity and/or debt to support expanded investment focus and increased loan demand.
If federal rescheduling of cannabis occurs, management anticipates increased capital inflows and improved recoveries on troubled loans.
Pipeline of new investments has declined due to limited real estate-backed opportunities and tighter underwriting standards amid industry volatility.
Positioned to capitalize on a growing U.S. cannabis market projected to reach $63 billion by 2030, with a 12% CAGR.
Latest events from Advanced Flower Capital
- Q1 2026 net investment income was $4.8M, NAV per share rose to $7.90, and a $5M buyback was authorized.AFCG
Q1 20267 May 2026 - BDC conversion expanded investment scope; $1.4B pipeline, $366M principal outstanding in 2025.AFCG
Q4 202527 Apr 2026 - Cannabis lending platform delivers 20% yields and strong dividends amid rapid industry growth.AFCG
Investor presentation24 Apr 2026 - Board recommends director elections and auditor ratification, with strong governance and oversight.AFCG
Proxy filing17 Apr 2026 - Vote on director elections and auditor ratification at the May 2026 annual meeting.AFCG
Proxy filing17 Apr 2026 - Q2 net income reached $16.4M as the company became a pure-play cannabis lender.AFCG
Q2 20242 Feb 2026 - Q3 2024 earnings met targets, with strong originations and higher risk post-CRE spin-off.AFCG
Q3 202414 Jan 2026 - Exceeded origination targets, delivered strong yields, and maintained a robust pipeline.AFCG
Q4 202424 Dec 2025 - REIT lender to cannabis sector files $1B shelf registration for flexible equity and debt offerings.AFCG
Registration Filing16 Dec 2025